Perpetual Ltd’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.24M | Sell |
134,576
-226
| -0.2% | -$5.91K | 0.05% | 142 |
|
|
2026
Q1 | $3.79M | Buy |
134,802
+4,750
| +4% | +$126K | 0.06% | 127 |
|
|
2025
Q4 | $3.24M | Buy |
130,052
+18,660
| +17% | +$471K | 0.05% | 146 |
|
|
2025
Q3 | $2.84M | Sell |
111,392
-25,064
| -18% | -$619K | 0.04% | 168 |
|
|
2025
Q2 | $3.31M | Sell |
136,456
-308
| -0.2% | -$7.18K | 0.04% | 160 |
|
|
2025
Q1 | $3.47M | Buy |
136,764
+13,060
| +11% | +$342K | 0.04% | 159 |
|
|
2024
Q4 | $3.28M | Buy |
123,704
+29,692
| +32% | +$805K | 0.04% | 158 |
|
|
2024
Q3 | $2.72M | Sell |
94,012
-674
| -0.7% | -$19.7K | 0.03% | 165 |
|
|
2024
Q2 | $2.65M | Buy |
94,686
+26,349
| +39% | +$725K | 0.03% | 187 |
|
|
2024
Q1 | $1.9M | Sell |
68,337
-118
| -0.2% | -$3.27K | 0.02% | 221 |
|
|
2023
Q4 | $1.97M | Sell |
68,455
-41,777
| -38% | -$1.26M | 0.02% | 207 |
|
|
2023
Q3 | $3.66M | Buy |
110,232
+52,074
| +90% | +$1.84M | 0.04% | 176 |
|
|
2023
Q2 | $2.13M | Sell |
58,158
-88,179
| -60% | -$3.43M | 0.02% | 236 |
|
|
2023
Q1 | $5.97M | Buy |
+146,337
| New | +$6.32M | 0.05% | 178 |
|
|
2020
Q3 | $2.4M | Hold |
68,956
| – | – | 0.17% | 156 |
|
|
2020
Q2 | $2.14M | Buy |
+68,956
| New | +$2.34M | 0.2% | 109 |
|
|
2020
Q1 | – | Sell |
-68,956
| Closed | -$2.56M | – | 236 |
|
|
2019
Q4 | $2.56M | Hold |
68,956
| – | – | 0.38% | 50 |
|
|
2019
Q3 | $2.35M | Buy |
68,956
+3,689
| +6% | +$134K | 0.36% | 55 |
|
|
2019
Q2 | $2.68M | Sell |
65,267
-12,753
| -16% | -$506K | 0.43% | 47 |
|
|
2019
Q1 | $3.14M | Hold |
78,020
| – | – | 0.45% | 46 |
|
|
2018
Q4 | $3.18M | Hold |
78,020
| – | – | 0.48% | 41 |
|
|
2018
Q3 | $3.26M | Sell |
78,020
-12,859
| -14% | -$495K | 0.44% | 49 |
|
|
2018
Q2 | $3.13M | Buy |
90,879
+5,059
| +6% | +$173K | 0.38% | 54 |
|
|
2018
Q1 | $2.89M | Sell |
85,820
-1,475
| -2% | -$50.7K | 0.39% | 46 |
|
|
2017
Q4 | $3.02M | Sell |
87,295
-949
| -1% | -$32.4K | 0.39% | 51 |
|
|
2017
Q3 | $3.05M | Hold |
88,244
| – | – | 0.43% | 49 |
|
|
2017
Q2 | $2.81M | Buy |
88,244
+4,427
| +5% | +$140K | 0.22% | 122 |
|
|
2017
Q1 | $2.71M | Buy |
+83,817
| New | +$2.64M | 0.27% | 82 |
|
|
2016
Q4 | – | Sell |
-64,002
| Closed | -$2.06M | – | 201 |
|
|
2016
Q3 | $2.06M | Sell |
64,002
-106,154
| -62% | -$3.55M | 0.17% | 131 |
|
|
2016
Q2 | $5.68M | Sell |
170,156
-2,635
| -2% | -$84.1K | 0.57% | 56 |
|
|
2016
Q1 | $4.86M | Hold |
172,791
| – | – | 0.49% | 63 |
|
|
2015
Q4 | $5.29M | Buy |
172,791
+26,350
| +18% | +$829K | 0.59% | 53 |
|
|
2015
Q3 | $4.36M | Sell |
146,441
-18,972
| -11% | -$608K | 0.52% | 53 |
|
|
2015
Q2 | $5.26M | Sell |
165,413
-5,270
| -3% | -$172K | 0.6% | 47 |
|
|
2015
Q1 | $5.63M | Sell |
170,683
-25,928
| -13% | -$824K | 0.63% | 42 |
|
|
2014
Q4 | $5.81M | Buy |
196,611
+8,748
| +5% | +$251K | 0.68% | 51 |
|
|
2014
Q3 | $5.27M | Sell |
187,863
-11,594
| -6% | -$325K | 0.57% | 56 |
|
|
2014
Q2 | $5.62M | Buy |
199,457
+36,363
| +22% | +$1.04M | 0.5% | 55 |
|
|
2014
Q1 | $4.97M | Buy |
163,094
+9,486
| +6% | +$283K | 0.73% | 49 |
|
|
2013
Q4 | $4.46M | Sell |
153,608
-41,077
| -21% | -$1.2M | 0.59% | 48 |
|
|
2013
Q3 | $5.3M | Sell |
194,685
-88,876
| -31% | -$2.42M | 0.75% | 42 |
|
|
2013
Q2 | $7.54M | Buy |
+283,561
| New | +$7.83M | 1.13% | 28 |
|
Other funds holding PFE
AIM
CWP
DADC
Perpetual Ltd's PFE Position: Q2 2026 in Review
Perpetual Ltd reduced its Pfizer (PFE) stake by 0.17% in Q2 2026, selling an estimated $5.91K and leaving 134,576 shares worth $3.24M. The position accounts for 0.05% of the portfolio, ranked #142.
Perpetual Ltd first reported a position in PFE in Q2 2013 and has held it in 42 quarters since. The position peaked at $7.54M in Q2 2013. 1,106 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Perpetual Ltd held 134,576 shares of Pfizer worth $3.24M as of Q2 2026.
- Perpetual Ltd sold 226 Pfizer shares in Q2 2026, an estimated $5.91K.
- Pfizer made up 0.05% of Perpetual Ltd's portfolio in Q2 2026, its #142 holding.
- Perpetual Ltd first reported a position in Pfizer in Q2 2013 and has held it in 42 quarters since.
- Perpetual Ltd's Pfizer position peaked at $7.54M in Q2 2013.
- 1,106 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Perpetual Ltd's 13F filing for Q2 2026, filed 15 Jul 2026.